Saturday 17 October 2026 Export ZVSA’s income statement to Excel — free account

ZyVersa Therapeutics, Inc.

ZVSA Healthcare Biotechnology

In the quarter to March 2026, EPS grew 69.9% and free cash flow grew 54.9%, each against the same quarter a year earlier.

0.05 0.00 0.00%

Follow ZVSA

Alert me

Market cap: $970.0K
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '25	Sep '25	Dec '25	Mar '26
ROE Full definition →	+8 more TTM periods Free account	(112.65%)	1,093.82%	1,289.40%	817.13%
ROA Full definition →		(42.40%)	(251.13%)	(236.93%)	(225.42%)
ROIC Full definition →		(80.31%)	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		68.29%	218.31%	201.45%	173.38%
Free Cash Flow per Share Full definition →		(1.06)	(0.76)	(0.86)	(0.51)
Free Cash Flow Full definition →		(5.12)	(5.92)	(5.11)	(4.14)
Other line items
Cash ROIC Full definition →		(83.00%)	52.83%	41.63%	29.96%
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	(0.05)	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		(14.91)	(50.52)	(49.66)	(46.85)
Operating CF/Net income Full definition →		0.62	0.23	0.21	0.17
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.06)	(0.76)	(0.86)	(0.51)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates